Condition

Adverse Effect

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 5 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials5

Recruiting0

Common interventions5

Lead sponsors shown2

Clinical trials

5 shown

Phenylephrine Prophylaxis for Postspinal Anesthesia Hypotension in Parturients With PreeclampsiaNCT04576663 · 2023-10-01

UNKNOWN

The Potency of Prophylactic Norepinephrine and Phenylephrine Boluses for Postspinal Anesthesia HypotensionNCT05035472 · 2023-01-01

UNKNOWN

Norepinephrine Prophylaxis for Postspinal Anesthesia Hypotension in Parturients With Preeclampsia.NCT04556370 · 2021-11-16

COMPLETED

Norepinephrine Prophylaxis for Postspinal Anesthesia Hypotension in Parturients With PreeclampsiaNCT04556357 · 2020-09-22

COMPLETED

Efﬁcacy and Safety of Weight-Based Insulin Titration Regimen in Hospitalized Patients With Type 2 DiabetesNCT03220919 · 2017-06-01

UNKNOWN

Common interventions

NorepinephrineDRUG3 PhenylephrineDRUG3 Normal salineDRUG2 Glucose level-basedOTHER1 Weight-basedOTHER1

Mapped drugs appearing in these trials

Shared trial participation only; not evidence of efficacy or approval.

norepinephrine3 phenylephrine3

Leading sponsors

General Hospital of Ningxia Medical University 4 Second Affiliated Hospital of Guangzhou Medical University 1

Trial status mix

UNKNOWN3

COMPLETED2

Phase mix

NA5

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.